EDESA BIOTECH, INC. Stock Issued During Period, Shares, Period Increase (Decrease)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2016-06-30 was 0.00 shares.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2016-03-31 was 0.00 shares.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2015-12-31 was 464.00K shares, a 3559.31% increase year-over-year.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2015-09-30 was 30.09K shares.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for fiscal 2015 was 42.77K shares, a 97.90% decline from fiscal 2014.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for fiscal 2014 was 2.03M shares, a 62.16% increase from fiscal 2013.
- EDESA BIOTECH, INC. stock issued during period, shares, period increase (decrease) for fiscal 2013 was 1.25M shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) 3 month | Stock Issued During Period, Shares, Period Increase (Decrease) 12 month |
|---|---|---|
| 2016-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 494.09K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | 494.09K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-12-31 | 464.00K shares 10-Q · filed 2016-02-08 | 494.09K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-09-30 | 30.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | 42.77K shares 10-K · filed 2015-12-14 |
| 2015-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | |
| 2015-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | |
| 2014-12-31 | 12.68K shares 10-Q · filed 2016-02-08 | |
| 2014-08-31 | 2.03M shares 10-K · filed 2015-12-14 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | |
| 2014-03-31 | 2.26M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | |
| 2013-12-31 | 4.22M shares 10-Q · filed 2015-02-09 | |
| 2013-08-31 | 1.25M shares 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |